13. Multiple sclerosis/Neuromyelitis optica
3,050 clinical trials,   2,147 drugs   (DrugBank: 348 drugs),   244 drug target genes,   228 drug target pathways
Searched query = "Multiple sclerosis/Neuromyelitis optica", "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04096443 (ClinicalTrials.gov) | October 28, 2019 | 7/8/2019 | Oral FMT (Fecal Microbial Transplant) in Subjects With Multiple Sclerosis | A Pilot Study of Oral FMT (Fecal Microbial Transplant) in Subjects With Multiple Sclerosis | Multiple Sclerosis | Biological: Fecal microbial transplant (FMT) | Griffin Hospital | Yale-Griffin Prevention Research Center;Multiple Sclerosis Treatment Center, Derby, Connecticut | Recruiting | 18 Years | 40 Years | All | 15 | Early Phase 1 | United States |